Detection of scleroderma with capillaroscopic abnormalities of nailfolds

International Journal of Dermatology

Volumn 35, Issue 12, 1996, Pages 857-861

  Maeda, Manabu ^a   Ichiki, Yosiro ^a   Shikano, Yukiko ^a   Mori, Shunji ^a   Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

EID: 0030467107     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb05051.x     Document Type: Article

References (15)

1. Barnett AJ. Scleroderma (progressive systemic sclerosis). Springfield: Charles C Thomas, 1974:71-93.
2. Maeda M, Mori S. Occupational or extrinsic factors and initial signs of progressive systemic sclerosis. Int J Dermatol 1992; 31:257-259.
3. Maeda M, Matubara K, Hirano H, et al. Pitting scars in progressive systemic sclerosis. Dermatology 1993; 187:104-108.
4. Inaba R, Maeda M, Fujita S, et al. Prevalence of Raynaud's phenomenon and specific clinical signs related to progressive systemic sclerosis in the general population of Japan. Int J Dermatol 1993; 32:652-655.
5. Maricq HR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24:1159-1165.
6. Maricq HR. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23:183-189.
7. Maricq HR, Weinberger AB, LeRoy EC. Early detection of scleroderma spectrum disorders by in vivo capillary microscopy - a prospective study of patients with Raynaud's phenomenon. J Rheumatol 1982; 9:289-291.
8. Maricq HR, Weinrich MC, Keil JE, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32:998-1006.
9. Koshino Y, Takai T, Kato T, et al. Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to the disease severity. Gastroenterol Jpn 1991; 26:575-581.
10. Ishikawa H. Revised diagnostic criteria for progressive systemic sclerosis. Ryumachi 1984; 24:198-203.
11. Mori S. Preliminary diagnostic criteria in Japan. International Scleroderma Symposium. "Current topics in scleroderma." Gifu, Japan: Seino Printing, 1992:17-26.
12. Fleishmajer R, Jerome S, Perlish JS. Capillary alterations in scleroderma. J Am Acad Dermatol 1980; 2: 161-170.
13. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970; 73:317-324.
14. Chen ZY, Silver RM, Ainsworth SK, et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77:812-822.
15. Moroi Y, Peebles C, Fritzler MJ, et al. Autoantibody to centomere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A 1980; 77:1627-1631.